Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review

S Łukasiewicz, M Czeczelewski, A Forma, J Baj… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is the most common cancer among women. It is estimated
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …

Roles of IFN-γ in tumor progression and regression: a review

D Jorgovanovic, M Song, L Wang, Y Zhang - Biomarker research, 2020 - Springer
Background Interferon-γ (IFN-γ) plays a key role in activation of cellular immunity and
subsequently, stimulation of antitumor immune-response. Based on its cytostatic, pro …

The great immune escape: understanding the divergent immune response in breast cancer subtypes

SS Onkar, NM Carleton, PC Lucas, TC Bruno, AV Lee… - Cancer discovery, 2023 - AACR
Breast cancer, the most common type of cancer affecting women, encompasses a collection
of histologic (mainly ductal and lobular) and molecular subtypes exhibiting diverse clinical …

Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical …

SD Jayasingam, M Citartan, TH Thang… - Frontiers in …, 2020 - frontiersin.org
Tumor-associated macrophages (TAMs) as immune cells within the tumor microenvironment
have gained much interests as basic science regarding their roles in tumor progression …

Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance

R Upton, A Banuelos, D Feng… - Proceedings of the …, 2021 - National Acad Sciences
Trastuzumab, a targeted anti-human epidermal-growth-factor receptor-2 (HER2) monoclonal
antibody, represents a mainstay in the treatment of HER2-positive (HER2+) breast cancer …

M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer

M Oshi, Y Tokumaru, M Asaoka, L Yan… - Scientific reports, 2020 - nature.com
Tumor associated macrophages (TAMs) play a critical role in biology of various cancers,
including breast cancer. In the current study, we defined “M1” macrophage and “M1”/“M2” …

Macrophage biology and mechanisms of immune suppression in breast cancer

AK Mehta, S Kadel, MG Townsend, M Oliwa… - Frontiers in …, 2021 - frontiersin.org
Macrophages are crucial innate immune cells that maintain tissue homeostasis and defend
against pathogens; however, their infiltration into tumors has been associated with adverse …

Tumor-associated macrophages: An effective player of the tumor microenvironment

U Basak, T Sarkar, S Mukherjee… - Frontiers in …, 2023 - frontiersin.org
Cancer progression is primarily caused by interactions between transformed cells and the
components of the tumor microenvironment (TME). TAMs (tumor-associated macrophages) …

Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy

SU Khan, MU Khan, M Azhar Ud Din, IM Khan… - Frontiers in …, 2023 - frontiersin.org
In the last ten years, it has become increasingly clear that tumor-infiltrating myeloid cells
drive not just carcinogenesis via cancer-related inflammatory processes, but also tumor …

Resistance to trastuzumab

S Vivekanandhan, KL Knutson - Cancers, 2022 - mdpi.com
Simple Summary Trastuzumab is a humanized antibody that has significantly improved the
management and treatment outcomes of patients with cancers that overexpress HER2 …